Blog

Convert GWAS Discoveries into Robust Molecular Markers with PACE®

Convert GWAS Discoveries into Robust Molecular Markers with PACE®

Genome-wide association studies (GWAS) and genotyping-by-sequencing (GBS) have transformed genetic research, enabling the discovery of thousands of SNPs and InDels linked to important traits across plant and animal populations. However, discovery is only the first step. To translate these findings into real-world breeding impact—whether improving crop yield, disease resistance, productivity, or animal performance—robust validation and scalable screening of these markers is essential.

Many breeding programs successfully identify promising markers through GWAS but face significant challenges when transitioning those discoveries into routine screening workflows. Sequencing-based validation can quickly become expensive, time-consuming, and difficult to scale across large breeding populations.

This is where PACE® genotyping technology, based on allele-specific PCR, plays a critical role—providing a practical, cost-effective solution for converting genomic discoveries into routine breeding decisions.

From Discovery to Application: The GWAS Bottleneck

GWAS generates vast datasets, identifying candidate markers associated with traits of interest. However, these markers must be:

  • Validated across diverse populations
  • Confirmed for accuracy and reproducibility
  • Screened efficiently at scale within breeding pipelines

While sequencing technologies excel at marker discovery, they are not always practical for routine breeding operations where rapid turnaround, lower costs, and targeted marker panels are required.

Using sequencing-based approaches for this stage is often impractical. While powerful for discovery, next-generation sequencing (NGS) methods such as GBS can be:

  • Costly when applied to routine screening
  • Data-intensive and slow to analyse
  • Inefficient for small to medium marker panels
  • Dependent on complex bioinformatics workflows

For many breeding programs, this creates a gap between marker discovery and real-world implementation.

Breeding programs need a method that bridges the gap between discovery and deployment—delivering speed, accuracy, scalability, and cost-efficiency without adding unnecessary workflow complexity.

PACE®: Purpose-Built for Marker Validation and Screening

PACE® (PCR Allele Competitive Extension) genotyping offers a robust and scalable solution for SNP and InDel marker validation. Designed for flexibility and throughput, it is particularly well suited for the focused marker panels that emerge from GWAS studies.

Unlike sequencing workflows that require extensive data processing and specialist analysis, PACE® delivers straightforward allele calls that can be rapidly integrated into breeding decisions and marker-assisted selection programs.

Exceptional Accuracy and Specificity

PACE® leverages allele-specific PCR to discriminate between genetic variants with high precision. This ensures:

  • Reliable differentiation of SNP alleles
  • Consistent detection of InDels
  • High-confidence confirmation of marker-trait associations

This level of specificity is essential when confirming GWAS findings and establishing reliable markers for downstream breeding applications.

By generating highly reproducible genotype data, PACE® helps researchers reduce false positives and make more confident selection decisions.

Proven Performance Across Species

PACE® technology is widely adopted across plant and animal breeding research, with numerous peer-reviewed studies demonstrating:

  • High concordance with sequencing data
  • Reproducible results across laboratories
  • Robust performance across diverse genomes

PACE® chemistry is trusted across crop, livestock, horticulture, and aquaculture applications for reliable high-throughput SNP genotyping.

This track record gives researchers confidence when transitioning from discovery datasets to applied breeding workflows.

Bovine SNP panels for genetic research

Scalable Throughput for Real-World Breeding

PACE® is ideally suited for genotyping anywhere from a handful to hundreds of markers across large sample sets. This makes it perfect for:

  • Screening breeding populations
  • Validating markers across environments
  • Supporting marker-assisted selection (MAS)
  • Enabling genomic selection workflows

Its compatibility with high-throughput workflows allows breeding programs to scale efficiently without compromising data quality or increasing operational complexity.

PACE® also helps reduce delays between marker discovery and breeding implementation, enabling faster selection cycles and more responsive breeding programs.

Cost-Effective Genotyping for Routine Screening

Compared to sequencing-based methods, PACE® significantly reduces per-sample and per-marker costs. This enables:

  • Routine, large-scale screening
  • More frequent testing cycles
  • Better resource allocation within breeding programs
  • Cost-effective deployment of targeted marker panels

For programs working with defined marker sets, this affordability makes routine molecular screening more commercially viable and operationally sustainable.

Lower genotyping costs also make it feasible to screen larger breeding populations more frequently, improving selection accuracy without inflating program budgets.

Aligned with 3CR’s mission of making science affordable, PACE® helps breeding programs implement high-quality genotyping at scale.

Flexibility and Custom Assay Design

One of PACE®’s key strengths is its adaptability. Researchers can design assays targeting specific SNPs or InDels identified through GWAS, allowing them to:

  • Focus only on relevant markers
  • Rapidly deploy new assays as discoveries emerge
  • Tailor genotyping panels to specific traits or populations

This flexibility is critical in fast-moving research and breeding environments where new discoveries must be translated quickly into practical screening tools.

3CR also offers complimentary PACE® assay design support, helping researchers rapidly convert GWAS discoveries into deployable genotyping assays.

PACE® master mixes are fully compatible with PACE®, KASP™ and Amplifluor® assays, simplifying integration into existing workflows.

Explore how flexible PACE® assay design can simplify marker validation and routine screening in your breeding workflow.

Hordeum samples for genetic SNP genotyping

Strengthening Marker-Trait Validation

Validating marker-trait associations is fundamental to successful breeding strategies. PACE® enables researchers to:

  • Test markers across diverse germplasm
  • Confirm robustness under different environmental conditions
  • Eliminate false positives from GWAS datasets
  • Generate consistent, reproducible genotype data

This improves confidence in marker performance and supports the development of reliable molecular breeding strategies.

For breeding teams moving discoveries into commercial pipelines, robust validation is essential for reducing risk and improving selection consistency.

Enabling Genomic Selection and Accelerated Breeding

Once validated, markers can be integrated into genomic selection models. PACE® provides the reliable genotypic data needed to:

  • Improve prediction accuracy
  • Estimate breeding values more effectively
  • Accelerate selection cycles
  • Support faster genetic gain

By enabling rapid, cost-effective screening, PACE® helps breeders make faster, data-driven decisions across breeding populations.

This is particularly valuable for breeding programs aiming to scale genomic selection without relying solely on sequencing-based workflows.

Why PACE® Stands Out

Rather than replacing sequencing technologies, PACE® complements them by providing a practical platform for routine marker validation and high-throughput screening.

It combines:

  • The precision needed for validation
  • The throughput required for large-scale screening
  • The cost-efficiency essential for routine use
  • The workflow simplicity needed for real-world breeding operations

For breeding programs seeking to transition from genomic discovery into practical implementation, PACE® provides a scalable and commercially sustainable solution.

Move from genomic discovery to scalable breeding decisions with PACE® genotyping. Discover how 3CR helps breeding programs implement reliable, cost-effective marker screening workflows.

Conclusion

GWAS and sequencing technologies have unlocked unprecedented insights into genetic variation, but their true value lies in application. PACE® genotyping empowers researchers and breeders to validate, refine, and deploy these discoveries with confidence.

By offering a robust, flexible, and cost-effective platform for SNP and InDel genotyping, PACE® helps bridge the gap between genomic discovery and applied breeding.

Whether validating newly discovered GWAS markers or scaling routine breeding assays, PACE® enables breeding programs to implement molecular markers faster, more efficiently, and more affordably.

With flexible assay design, high-throughput compatibility, and proven performance across species, 3CR helps researchers turn genomic insights into measurable breeding progress—while continuing to make science affordable.

MORE POSTS

Convert GWAS Discoveries into Robust Molecular Markers with PACE®
Discover how PACE® genotyping helps breeders turn GWAS discoveries into fast, scalable, and cost-effective molecular screening tools for real-world breeding success.
Solving Common Plant and Seed DNA Extraction Challenges with User Friendly Kits and Scalable Automation
Discover seven common plant and seed DNA extraction challenges—and how optimised chemistry combined with MagC 384 automation helps deliver consistent, high-quality DNA at scale.
Leaf Sample Collection Kit – User Guide
Ensure high-quality DNA extraction results by following our step-by-step guide to collecting, storing, and shipping leaf samples correctly.

Our product portfolio for your PCR genotyping workflow

Our portfolio of products and services include PACE® genotyping chemistry, instruments, and lab services to streamline every step of your workflow. Designed for life sciences, biotech, and agricultural research, our high-performance reagents, reliable instruments, and expert lab support help you achieve accurate, consistent results while reducing time and costs – making science affordable.

[fibosearch]
This field is for validation purposes and should be left unchanged.
Name(Required)

Contact us

Resolve Genotyping Challenges. With One Practical Guide.

From failed amplification to scattered cluster plots — this guide provides structured, expert-backed solutions for the 7 most common PACE® genotyping issues.

"(Required)" indicates required fields

This field is for validation purposes and should be left unchanged.
I’d like to sign up for the newsletter

MEET OUR TEAM

Steve AsquithManaging Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John HolmeTechnical Director

John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base.

During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Dr. Nisha JainOperations Director

Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP.

Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Nazma SaffinGeneral Manager

For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.

Greig PollandAutomation and Support Manager

Greig is a hands-on automation specialist and team leader with a strong background in laboratory and industrial automation. He has spent over 25 years developing, installing, and supporting automated systems that transformed laboratory workflows. During this time, Greig worked closely with scientists and engineers to tailor automation solutions for genotyping and molecular biology, an experience that sparked his lasting passion for combining technology with practical science.

Since then, Greig has built on that foundation through leadership roles where he leads automation and support operations. He’s known for being approachable, commercially minded, and deeply committed to helping teams and customers get the best from their technology.

Whether managing a complex automation rollout or helping a customer troubleshoot in real time, Greig brings a thoughtful, collaborative approach that keeps people ,not just machines, at the centre of what he does.

Daniel LawsonMarketing Manager
Daniel is a strategically minded marketing and communications professional with over a decade of experience delivering integrated, multi-channel campaigns across healthcare, legal and not-for-profit sectors. He has a strong track record in building brand visibility, driving engagement and supporting revenue growth through audience-focused marketing.
Prior to joining 3CR Bioscience in 2025, Daniel held senior marketing roles where he led strategic communications, managed brand development and delivered high-impact digital and content campaigns. His experience spans SEO, CRM, PR, events and stakeholder engagement, with a particular strength in translating complex messages into clear, compelling content.
At 3CR Bioscience, Daniel is responsible for shaping and executing the company’s marketing strategy, enhancing brand presence and supporting commercial growth through targeted, data-driven campaigns.